Remove Biosimilars Remove Compounding Remove Process Improvement
article thumbnail

The next frontier: Global leadership in biopharma

Express Pharma

Sasmitha Sahu, Managing Consultant, GlobalData states, “While India has demonstrated success in generic drug production, the same is not true for novel and biosimilar biopharma products.” These trends serve as crucial catalysts, necessitating a shift in priorities and a much-needed transformation of the manufacturing sector.”